Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma Treatment in COVID-19 Patients
NCT04476888Completed
- Sponsor
- Aga Khan University
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Aga Khan University. Primary endpoints: Decrease length of stay at 1 month, Overall mortality at 1 month and 1 more. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04476888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476888.